Patent details

Basic Information

Publication number:

EP2301541

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP101786572

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Antibiotic compositions for treatment of the eye

French Title of Invention:

Compositions antibiotiques destinees au traitement des yeux

German Title of Invention:

Antibiotische Zusammensetzungen zur Behandlung der Augen

SPC Number:

Dates

Filing date:

29/09/1999

Grant date:

20/08/2014

EP Publication Date:

20/08/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/03/2011

EP B1 Publication Date:

20/08/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

29/09/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/12/2019

 

 

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

History of Owners

From:

12/12/2019

To:

12/12/2019

Name:

Alcon Pharmaceuticals Ltd.

Address:

Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland (CH)

From:

01/12/2014

To:

12/12/2019

Name:

Alcon Pharmaceuticals Ltd.

Address:

Route des Arsenaux 41, 1701 Fribourg, Switzerland (CH)

Inventor

1

Name:

Abshire Robert L.

Address:

United States (US)

2

Name:

Stroman David W.

Address:

United States (US)

3

Name:

Yanni John M.

Address:

United States (US)

4

Name:

Cagle Gerald

Address:

United States (US)

Priority

1

Priority Number:

102506 P

Priority Date:

30/09/1998

Priority Country:

United States (US)

2

Priority Number:

102504 P

Priority Date:

30/09/1998

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/435;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20190000458A

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changement d'adresse

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Alcon Pharmaceuticals Ltd.

Address:

Rue Louis-d'Affry 6, 1701 Fribourg, Switzerland (CH)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000458B

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/09/2018

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
12/12/2019	Request For Change	4
24/12/2019	Outgoing Correspondence	1